Ann Neurol

1. CALABRESE M, Preziosa P, Scalfari A, Colato E, et al
   Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis.
   Ann Neurol. 2024 Apr 3. doi: 10.1002/ana.26913.
   

   >> Share

   
   
2. NEIDHART S, Vlad B, Hilty M, Hogelin KA, et al
   HLA Associations of Intrathecal IgG Production against Specific Viruses in Multiple Sclerosis.
   Ann Neurol. 2024 Mar 29. doi: 10.1002/ana.26921.
   

   >> Share

   
   

   
   BMC Neurol

3. CARDENAS-ROBLEDO S, Arenas-Vargas LE, Arenas RD, Gaspar-Toro JM, et al
   Treatment patterns and persistence on disease modifying therapies for multiple sclerosis and its associated factors.
   BMC Neurol. 2024;24:108.
   

   >> Share

   
   

   
   Hum Immunol

4. BOULLERNE AI, Goudey B, Paganini J, Erlichster M, et al
   Validation of tag SNPs for multiple sclerosis HLA risk alleles across the 1000 genomes panel.
   Hum Immunol. 2024 Apr 3:110790. doi: 10.1016/j.humimm.2024.110790.
   

   >> Share

   
   

   
   Int J Neurosci

5. GHARIGHNIA S, Omidi A, Ragerdi Kashani I, Sepand MR, et al
   Ameliorative effects of acetyl-L-carnitine on corpus callosum and functional recovery in demyelinated mouse model.
   Int J Neurosci. 2024;134:409-419.
   

   >> Share

   
   

   
   J Neuroimmunol

6. SRIWASTAVA S, Elkhooly M, Amatya S, Shrestha K, et al
   Recent advances in the treatment of primary and secondary progressive Multiple Sclerosis.
   J Neuroimmunol. 2024;390:578315.
   

   >> Share

   
   

   
   J Neurol

7. HUA T, Fan H, Duan Y, Tian D, et al
   Spinal cord and brain atrophy patterns in neuromyelitis optica spectrum disorder and multiple sclerosis.
   J Neurol. 2024 Apr 1. doi: 10.1007/s00415-024-12281.
   

   >> Share

   
   
8. GLASER A, Butzkueven H, van der Walt A, Gray O, et al
   Big Multiple Sclerosis Data network: an international registry research network.
   J Neurol. 2024 Apr 1. doi: 10.1007/s00415-024-12303.
   

   >> Share

   
   
9. GUERRIERI S, Rubin M, Gattuso I, Zanetta C, et al
   Can treatment adverse events be optimized by switching between different sphingosine 1-phosphate receptor modulators in multiple sclerosis? A case series.
   J Neurol. 2024 Apr 2. doi: 10.1007/s00415-024-12342.
   

   >> Share

   
   
10. SIGNORIELLO E, Foschi M, Lanzillo R, Frau J, et al
    Pregnancy effect on disease activity in women with multiple sclerosis treated with cladribine.
    J Neurol. 2024 Apr 3. doi: 10.1007/s00415-024-12291.
    

    >> Share

    
    
11. MAIDA E, Moccia M, Palladino R, Borriello G, et al
    ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis.
    J Neurol. 2024 Apr 3. doi: 10.1007/s00415-024-12328.
    

    >> Share

    
    
12. STEFANOU MI, Giannopapas V, Kitsos DK, Chondrogianni M, et al
    Prevalence and epidemiology of stroke in patients with multiple sclerosis: a systematic review and meta-analysis.
    J Neurol. 2024 Apr 4. doi: 10.1007/s00415-024-12331.
    

    >> Share

    
    
13. CELIK M, Baba C, Irmak C, Ozakbas S, et al
    Risk of hepatitis B virus reactivation in people with multiple sclerosis treated with ocrelizumab: an observational study from Turkey.
    J Neurol. 2024 Apr 5. doi: 10.1007/s00415-024-12333.
    

    >> Share

    
    

    
    J Neurol Neurosurg Psychiatry

14. MAHLER MR, Magyari M, Pontieri L, Elberling F, et al
    Prognostic factors for disease activity in newly diagnosed teriflunomide-treated patients with multiple sclerosis: a nationwide Danish study.
    J Neurol Neurosurg Psychiatry. 2024 Apr 3:jnnp-2023-333265.
    

    >> Share

    
    
15. DEKEYSER C, Hautekeete M, Cambron M, Van Pesch V, et al
    Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study.
    J Neurol Neurosurg Psychiatry. 2024 Apr 3:jnnp-2023-333307.
    

    >> Share

    
    

    
    Mult Scler

16. KWON S, Han KD, Jung JH, Cho EB, et al
    Risk of depression and anxiety in multiple sclerosis and neuromyelitis optica spectrum disorder: A nationwide cohort study in South Korea.
    Mult Scler. 2024 Apr 1:13524585241237093. doi: 10.1177/13524585241237093.
    

    >> Share

    
    

    
    Neurologia (Engl Ed)

17. RAMOS-GONZALEZ EJ, Bitzer-Quintero OK, Ortiz G, Hernandez-Cruz JJ, et al
    Relationship between inflammation and oxidative stress and its effect on multiple sclerosis.
    Neurologia (Engl Ed). 2024;39:292-301.
    

    >> Share

    
    

    
    PLoS One

18. IMRAISH A, Abu Thiab T, Alsalem M, Dahbour S, et al
    The neuroprotective effect of human primary astrocytes in multiple sclerosis: In vitro model.
    PLoS One. 2024;19:e0300203.
    

    >> Share

    
    
19. KAMPAITE A, Gustafsson R, York EN, Foley P, et al
    Brain connectivity changes underlying depression and fatigue in relapsing-remitting multiple sclerosis: A systematic review.
    PLoS One. 2024;19:e0299634.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share